Revitalizing lives, one spine at a time

The first regenerative fetal-inspired biomaterial to treat Low Back Pain (LBP) through a minimally invasive application.

The problem

Low back pain affects up to 85% of the people, ranking first in terms of years lived with disability.

150 billion € spent every year

150 million sick leave days lost

36,4% rise expected by 2050

The solution

Our solution can be injected into the patients’ spine either at early or late stages of degeneration, allowing for a full regenerative and long-term effect.

Learn more

The benefits

Efficient, Safe, and Sustainable Technology for Better Healthcare Solutions

Learn more

Full regenerative and long-term effect with a single injection

No need for risky surgeries and reoperations

Shortens intervention
time by 90%

Reduces hospitalization
stays by 70%

Promotes circular economy by using animal waste

Leads to significant
healthcare savings

Restores patients’ long active lives

Driving success

With years of expertise, prestigious awards, groundbreaking research, and key partnerships, we’ve built a catalyst for progress in the biotech space. The funding attracted has been cornerstone in positioning us to revolutionize healthcare.

10+

Years of study

Articles Published

>100k

Capital Raised

Our Awards

The opinion of experts

“This new treatment could potentially alter […] ageing, both in the terms of prevention […] but also reversing the biological condition, […] getting a spine that would be more functional with a minimally invasive procedure”

Nuno Neves (Orthopaedic Spine Surgeon) - Advisory Board Member